← Eichor
Study identifier: NCT05310448 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Tumor Treating Fields for the Treatment of Brainstem Gliomas

Condition: Glioma  ·  Sponsor: Emory University

PhaseNA
Planned participants10
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This clinical trial tests the safety and side effects of tumor treating fields in treating patients with gliomas located in the brainstem. Optune is a wearable, portable, treatment that creates low-intensity, wave-like electric fields called tumor treating fields (TTFields), which interfere with cancer cell division. TTFields may prevent growth or decrease size of gliomas in patients

This description comes directly from the study's public registry record.

Talk to the study team

Jim Zhong, MD  ·  404-778-3473  ·  jzhong@emory.edu

Always discuss trial participation with your own doctor first.

Locations (3)

Emory Proton Therapy CenterAtlanta, Georgia, United StatesNot Yet Recruiting
Emory University/Winship Cancer InstituteAtlanta, Georgia, United StatesRecruiting
Emory Saint Joseph's HospitalAtlanta, Georgia, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05310448